BroadOak completed a growth equity investment in EmVenio Research, alongside members of the company’s management team in September 2022. EmVenio Research is a Decentralized Clinical Trials (DCT) company originally launched as part of Matrix Medical Network in 2020. In 2022, the company was spun out and recapitalized by its management team. EmVenio provides DCT operational solutions, including project management, in-home visits, virtual visits, mobile sites, and on-site clinical support, for CROs, Pharma and Biotech companies.
Menu
Stay connected
Partner with BroadOak